Correction to: Oncogenic RIT1 mutations in lung adenocarcinoma

Oncogene. 2022 May;41(19):2788. doi: 10.1038/s41388-022-02300-2.

A H Berger^{1

2}, M Imielinski^{1

2

3

4}, F Duke¹, J Wala^{1

2

5}, N Kaplan², G -X Shi⁶, D A Andres⁶, M Meyerson^{7

8

9}

¹ Cancer Program, The Broad Institute of Harvard and M.I.T., 7 Cambridge Center, Cambridge, MA, USA.
² Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.
³ Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
⁴ Department of Pathology, Harvard Medical School, Boston, MA, USA.
⁵ Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, USA.
⁶ Department of Molecular and Cellular Biochemistry, University of Kentucky College of Medicine, Lexington, KY, USA.
⁷ Cancer Program, The Broad Institute of Harvard and M.I.T., 7 Cambridge Center, Cambridge, MA, USA. matthew_meyerson@dfci.harvard.edu.
⁸ Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA. matthew_meyerson@dfci.harvard.edu.
⁹ Department of Pathology, Harvard Medical School, Boston, MA, USA. matthew_meyerson@dfci.harvard.edu.

No abstract available

Publication types